Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic, St. Jude Will Not Take CRT Market Share, Guidant Vows

This article was originally published in The Gray Sheet

Executive Summary

Guidant expects to maintain its 38% share of the cardiac resynchronization therapy (CRT) market in the second half of 2004 despite a recent Medtronic launch and emerging competition from St. Jude

You may also be interested in...



St. Jude Expects To Take More CRT Share From Guidant Than Medtronic

Guidant's share of the cardiac resynchronization therapy (CRT) market is more vulnerable than that of Medtronic, according to St. Jude Medical CFO John Heinmiller

St. Jude Expects To Take More CRT Share From Guidant Than Medtronic

Guidant's share of the cardiac resynchronization therapy (CRT) market is more vulnerable than that of Medtronic, according to St. Jude Medical CFO John Heinmiller

St. Jude Commences Simultaneous Epic HF, Atlas+ HF CRT-D Launches

St. Jude Medical's entry into the cardiac resynchronization therapy (CRT) market will be supported by a 20% sales force expansion, from roughly 1,000 to 1,200 people this year

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel